Memo Therapeutics

Developer of antibodies for treating infectious diseases and cancer

placeSchlieren, Zurich, Switzerland calendar_todayFounded 2012 groups21 employees language memo-therapeutics.com

Social engagement

Social engagement: 7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include Pureos Bioventures, Swisscanto, Verve Ventures, Schroders Capital.

Investor typeCountShare
Venture capital1053%
Private equity15%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed632%

Recent activity

18 Jun 2026
Event
American Transplant Congress (ATC) 2026
3 Jun 2026
Event
63rd European Renal Association (ERA) Congress
27 May 2026
Partnership
CSL
Coming soon